News
European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis
Sanofi-aventis announced that the European Commission has cleared sanofi-aventis' proposed acquistion of Genzyme corporation unconditionally under EU merger control rules. Sanofi-aventis welcomes this decision, which is a requisite step in satisfaction of the condition to the...
News
Shionogi Inc announced availabilty of Kapvay
Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced a true milestone as it marks the first commercial availability for the noncentral nervous system stimulant medication KAPVAY, an extended-release oral formulation of clonidine for Attention Deficit...
News
Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system. This...
News
FDA extend review timeline for vandetanib new drug application
AstraZeneca announced that the US Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA) for the investigational drug vandetanib. Â As part of the...
News
Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has included roflumilast (Daxas®) as a new treatment option in its COPD management guidelines. A section on the new class, phosphodiesterase 4 (PDE4) inhibitors, describes the efficacy of roflumilast in...
News
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
Merck will hold its fourth-quarter 2010 sales and earnings conference call with institutional investors and analysts beginning at 8 a.m. EST on Thursday, Feb. 3. During the call, Kenneth C. Frazier, chief executive officer, Peter N. Kellogg, executive vice...
News
Teva Completes Acquisition of Theramex
Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of Theramex, Merck KGaA's European-based women's health business. Acquisition Provides Teva with a Strong Platform to Expand its Global Women's Health Franchise Theramex brings...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read